RE:Morningstar's Quantitative Equity Research Report for ATEYes - interesting. Thanks for the post.
Surely ... chronic had more uncertainty associated with it as it led us down the path to acute - for good reasons.
Also - acute likely leads us to strictly monitored chronic pain via pain specialists.
At higher dosing - wonder where it leads us on the peri-op side as well.
If we look at chronic over 14 days, we've handled 14 x 250 mg or 3500 mg in total without issue.
If we look at acute, going to guess less than 3000 mg over 10 days.
I think they forgot to add the word "less" in front of "extreme" in the uncertainty category.
Then again ... it's just my opinion. : )